Association of granulocyte transmigration with structural and cellular parameters of injury in experimental radiation enteropathy

Radiation Oncology Investigations

Volumn 5, Issue 6, 1997, Pages 275-282

  Richter, K K ^a   Fagerhol, M K ^b   Carr, J C ^a   Winkler, J M ^a   Sung, C C ^a   Hauer Jensen, M ^a,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Granulocytes; Intestines; Mucosa; Radiation injuries

Indexed keywords

CALPROTECTIN; CELL PROTEIN; GRANULOCYTE MARKER PROTEIN; INTERLEUKIN 1ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RADIOTHERAPY; CELL MIGRATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES LEVEL; GRANULOCYTE; HISTOPATHOLOGY; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION ENTEROPATHY; RAT; SMALL INTESTINE MUCOSA;

ANIMALS; BIOLOGICAL MARKERS; BLOOD PROTEINS; CELL MOVEMENT; CONFIDENCE INTERVALS; CULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FIBROSIS; GRANULOCYTES; INTERLEUKIN-1; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; RADIATION INJURIES, EXPERIMENTAL; RATS; RATS, SPRAGUE-DAWLEY; SENSITIVITY AND SPECIFICITY;

EID: 0031444887     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1997)5:6<275::AID-ROI3>3.0.CO;2-V     Document Type: Article

References (32)

1. Roseth AG, Fagerhol MK, Aadland E, Schjonsby H: Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 27:793-798, 1992.
2. Roseth AG, Kristinsson J, Fagerhol MK, Schjonsby H, Aadland E, Nygaard K, Roald B: Faecal calprotectin: A novel test for the diagnosis of colorectal cancer? Scand J Gastroenterol 28:1073-1076, 1993.
3. Langberg CW, Sauer T, Reitan JB, Hauer-Jensen M: Tolerance of rat small intestine to localized single dose and fractionated irradiation. Acta Oncol 31:781-787, 1992.
4. Hauer-Jensen M, Poulakos L, Osborne JW: Effects of accelerated fractionation on radiation injury of the small intestine: A new rat model. Int J Radiat Oncol Biol Phys 14:1205-1212, 1988.
5. Hauer-Jensen M, Theus JW, Bradley JD, Baker ML, Langberg CW: Localized subclinical radiation enteropathy prolongs intestinal transit time. An experimental study in a rat model. Radiat Oncol Invest 3:157-166, 1995.
6. Langberg CW, Hauer-Jensen M, Sung C-C, Kane CJM: Expression of fibrogenic cytokines in rat small intestine after fractionated irradiation. Radiother Oncol 32:29-36, 1994.
7. Hauer-Jensen M, Poulakos L, Osborne JW: Intestinal complications following accelerated fractionated X-irradiation. An experimental study in the rat. Acta Oncol 29:229-234, 1990.
8. Foster R, Roseth AG, Fagerhol MK, Somasundaram S, Peters TJ, Bjarnason I: Indomethacin enteropathy in rats assessed by a novel granulocytic marker protein (GMP) (abstract). World Cong Gastroenterol 10:1958P, 1994.
9. Hauer-Jensen M, Sauer T, Devik F, Nygaard K: Late changes following single dose roentgen irradiation of rat small intestine. Acta Radiol Oncol 22:299-303, 1983.
10. Arndt H, Palitzsch KD, Anderson DC, Rusche J, Grisham MB, Granger DN: Leucocyte-endothelial cell adhesion in a model of intestinal inflammation. Gut 37:374-379, 1995.
11. Beagley KW, Elson CO: Cells and cytokines in mucosal immunity and inflammation. Gastroenterol Clin North Am 21:347-365, 1991.
12. Handy LM, Ghosh S, Ferguson A: Investigation of neutrophils in the gut lumen by assay of granulocyte elastase in whole-gut lavage fluid. Scand J Gastroenterol 31:700-705, 1996.
13. Izzo RS, Witkon K, Chen AI, Hadjiyane C, Weinstein MI, Pellecchia C: Interleukin-8 and neutrophil markers in colonic mucosa from patients with ulcerative colitis. Am J Gastroenterol 87:1447-1452, 1992.
14. Bischoff SC, Grabowsky J, Manns MP: Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls. Dig Dis Sci 42:394-403, 1997.
15. O'Morain C, Smethurst P, Levi AJ, Peters TJ: Biochemical analysis of enzymic markers of inflammation in rectal biopsies from patients with ulcerative colitis and Crohn's disease. J Clin Pathol 36:1312-1316, 1983.
16. Fagerhol MK, Dale I, Andersson T: Release and quantitation of a leucocyte derived protein (LI). Scand J Haematol 24:393-398, 1980.
17. Richter KK, Sung C-C, Langberg CW, Hauer-Jensen M: Association of transforming growth factor β (TGF-β) immunoreactivity with specific histopathologic lesions in subacute and chronic experimental radiation enteropathy. Radiother Oncol 39:201-302, 1996.
18. Scott BR, Langberg CW, Hauer-Jensen M: Models for estimating the risk of ulcers in the small intestine after localized single or fractionated irradiation. Br J Radiol 57:49-57, 1995.
19. Roseth AG, Aadland E, Jahnsen J, Radnerud N: Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion 488:in press, 1997.
20. Radema SA, van Deventer SJH, Cerami A: Interleukin Iβ is expressed predominantly by enterocytes in experimental colitis. Gastroenterology 100:1180-1186, 1991.
21. Krawisz JE, Sharon P, Stenson WF: Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87:1344-1350, 1984.
22. Kane SP, Vincenti AC: Mucosal enzymes in human inflammatory bowel disease with reference to neutrophil granulocytes as mediators of tissue injury. Clin Sci 57:295-303, 1979.
23. 51Cr-EDTA in rats with experimentally induced enteropathy. Gut 26:579-585, 1985.
24. Solheim KE, Laerum F, Stordahl A, Aase S: Urinary excretion of iohexol after enterai administration in rats with radiation injury of the small intestine. Scand J Gastroenterol 26:1097-1106, 1991.
25. Ford J, Martin SW, Houston JB: Assessment of intestinal permeability changes induced by nonsteroidal anti-inflammatory drugs in the rat. J Pharmacol Toxicol Meth 34:9-16, 1995.
26. 99mTc]hexamethylpropyleneamine-oxime-labeled leukocyte scintigraphy in inflammatory bowel disease. Dig Dis Sci 41:412-420, 1996.
27. Arndt JW, Grootscholten MI, van Hogezand RA, Griffioen G, Lamers CBHW, Pauwels EKJ: Inflammatory bowel disease activity assessment using technetium99m-HMPAO leukocytes. Dig Dis Sci 42:387-393, 1997.
28. Parekh T, Saxena B, Reibman J, Cronstein BN, Gold LI: Neutrophil chemotaxis in response to TGF-β isoforms (TGF-β1, TGF-β2, TGF-β3) is mediated by fibronectin. J Immunol 152:2456-2466, 1994.
29. Lindner H, Holler E, Klauke I, Bornkamm GW, Eissner G: Irradiated peripheral blood mononuclear cells induce endothelial cell apoptosis (abstract). Radiother Oncol 40(S1):S125, 1996.
30. Glaser CB, Morser J, Clarke JH, Blasko E, McLean K, Kuhn I, Chang RJ, Lin JH, Vilander L, Andrews WH, et al.: Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. J Clin Invest 90:2565-2573, 1992.
31. Abe H, Okajima K, Okabe H, Takatsuki K, Binder BR: Granulocyte proteases and hydrogen peroxide synergistically inactivate thrombomodulin of endothelial cells in vitro. J Lab Clin Med 123:874-881, 1994.
32. Boehme MWJ, Deng Y, Raeth U, Bierhaus A, Ziegler R, Stremmel W, Nawroth PP: Release of thrombomodulin from endothelial cells by concerted action of TNF-α and neutrophils: In vivo and in vitro studies. Immunology 87:134-140, 1996.